D'ONGHIA, MARIANGELA
 Distribuzione geografica
Continente #
NA - Nord America 658
EU - Europa 78
AS - Asia 66
Continente sconosciuto - Info sul continente non disponibili 3
Totale 805
Nazione #
US - Stati Uniti d'America 657
CN - Cina 58
SE - Svezia 35
IT - Italia 16
FI - Finlandia 8
GB - Regno Unito 7
BE - Belgio 5
VN - Vietnam 4
DE - Germania 2
EU - Europa 2
HK - Hong Kong 2
SG - Singapore 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CA - Canada 1
FR - Francia 1
IE - Irlanda 1
RO - Romania 1
RU - Federazione Russa 1
UA - Ucraina 1
Totale 805
Città #
Fairfield 120
Woodbridge 91
Houston 67
Chandler 62
Ashburn 50
Seattle 47
Cambridge 36
Nyköping 26
Beijing 25
Ann Arbor 24
Wilmington 24
Jacksonville 10
Roxbury 10
Lawrence 8
Nanjing 7
Bari 6
Brooklyn 6
Des Moines 6
Norwalk 6
Princeton 6
Brussels 5
Shenyang 5
Dong Ket 4
Inglewood 4
Redwood City 4
San Diego 4
Dearborn 3
Hebei 3
Tianjin 3
Boardman 2
Hong Kong 2
Jesi 2
Jiaxing 2
London 2
Phoenix 2
Taranto 2
Brierley Hill 1
Chengdu 1
Chicago 1
Dalian 1
Dublin 1
Guangzhou 1
Guiyang 1
Hanover 1
Hefei 1
Irvine 1
Jinan 1
Kansas City 1
Leninsk-kuznetskiy 1
Lviv 1
Marseille 1
New Bedfont 1
Ningbo 1
Quzhou 1
Santa Marinella 1
Shanghai 1
Singapore 1
Toronto 1
Trani 1
Wuhan 1
Totale 710
Nome #
Long-term cardiac safety and tolerability of fingolimod in multiple sclerosis: A postmarketing study 125
The Cost of Patients With Relapsing-Remitting Multiple Sclerosis Who Develop Neutralizing Antibodies While Treated With Interferon Beta 117
The cost of relapsing-remitting multiple sclerosis patients who develop neutralizing antibodies during interferon beta therapy 103
Lymphocyte subsets as biomarkers of therapeutic response in Fingolimod treated Relapsing Multiple Sclerosis patients 100
Cerebrospinal fluid neurofilament light levels mark grey matter volume in clinically isolated syndrome suggestive of multiple sclerosis 90
Lymphocyte count and body mass index as biomarkers of early treatment response in a multiple sclerosis dimethyl fumarate-treated cohort 90
Long-Term Data of Efficacy, Safety, and Tolerability in a Real-Life Setting of THC/CBD Oromucosal Spray-Treated Multiple Sclerosis Patients 86
The role of neutralizing antibodies to interferon-β as a biomarker of persistent MRI activity in multiple sclerosis: a 7-year observational study 69
null 65
null 21
Totale 866
Categoria #
all - tutte 3.262
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.262


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020262 29 13 5 20 25 16 24 33 29 26 35 7
2020/2021151 16 10 12 10 12 12 21 13 8 18 9 10
2021/202292 6 6 0 2 5 10 4 5 8 11 16 19
2022/2023146 22 22 8 20 13 13 0 18 21 1 3 5
2023/202428 4 7 2 5 3 1 0 2 0 0 0 4
2024/20258 8 0 0 0 0 0 0 0 0 0 0 0
Totale 866